* Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's propriet...
* Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's propriet...
SINGAPORE, April 11, 2023 /PRNewswire/ -- ACM Biolabs (FR0012596468 – ALSEN) a pioneering Singapore...
SINGAPORE and BASEL, Switzerland and SYDNEY, July 29, 2022 /PRNewswire/ -- ACM
Biolabs